AmniSure® ROM Test - box of 10 tests

AmniSure^® is a new diagnostic device developed by N-Dia, Inc. that solves a long-standing problem in obstetric practice - diagnosis of ruptured fetal membranes (ROM). Premature ROM (PROM) occurs in about one out of ten pregnant women and constitutes the major factor of pre-and post-natal complications. In the U.S., at least 30% of pregnant women are checked for PROM during pregnancy

If the rupture of the amniotic sac that results in the leakage of the fluid is not detected and treated in a timely and accurate manner (within 24 hours from the occurrence of the rupture), infection and other serious complications for the neonate and the mother may occur. Diagnosis of ruptured fetal membranes is of crucial importance at any term in a pregnancy for prompt hospitalization and for timely and proper treatment.

How to use: http://www.youtube.com/user/amnisure

Features
 

• SIMPLE PROCEDURE - No need for speculum examination, additional reagents or equipment and the result can be evaluated visually
• ONE SHORT INCUBATION - Produces quick results - within minutes
• MONOCLONAL ANTIBODIES - New generation device employing immunochromatographic method
• ONE TEST - In trials, AmniSure^® correlated with the clinical diagnosis obtained through the combined usage of three routinely used tests (Nitrazine, Ferning, and Pooling)

The timely and accurate diagnosis of rupture of fetal membranes (ROM) is crucial since the ROM may be associated with serious neonatal and maternal consequences. Failure to identify ROM can result in the failure to implement salutary obstetric measures. Conversely, the false diagnosis of membranes rupture can lead to inappropriate interventions (e.g., hospitalization or induction of labor). Therefore the correct and timely diagnosis of ROM is of crucial importance for the clinician. Accurate diagnosis of fetal membranes rupture, however, remains a frequent clinical problem in obstetrics.